Clinical trial finds vitamin D does not ward off colds and flu

Clinical trial finds vitamin D does not ward off colds and flu

A QIMR Berghofer-led randomized controlled trial of vitamin D supplements has found they do not prot...
read more
Clinical histone deacetylase inhibitors are effective against COVID-19

Clinical histone deacetylase inhibitors are effective against COVID-19

COVID-19, caused by the SARS-CoV-2 virus, has pose...
read more
Unique wearable helps researchers study dementia patients and familial caregivers

Unique wearable helps researchers study dementia patients and familial caregivers

Couples with higher relationship satisfactions sho...
read more
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ &...
read more
Epic to launch customer story-sharing platform, Judy Faulkner says

Epic to launch customer story-sharing platform, Judy Faulkner says

Epic CEO Judy Faulkner said this past week that th...
read more
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update

Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update

GAITHERSBURG, Md., Oct. 27, 2020 (GLOBE ...
read more
'Hey Cerner': Company seeks health systems to help test new Voice Assist tech

'Hey Cerner': Company seeks health systems to help test new Voice Assist tech

As Cerner gears up to launch its new natural lang...
read more
Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine

Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2020&nb...
read more
Clinical study aims to better understand COVID-19 immunity

Clinical study aims to better understand COVID-19 immunity

People who have recovered from COVID-19, and their...
read more
Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19

Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19

FOSTER CITY, Calif.–(BUSINESS WIRE)–Oc...
read more